Protective effects of follicle-stimulating hormone inhibitor on alveolar bone loss resulting from experimental periapical lesions in ovariectomized rats
- PMID: 20307740
- DOI: 10.1016/j.joen.2010.01.011
Protective effects of follicle-stimulating hormone inhibitor on alveolar bone loss resulting from experimental periapical lesions in ovariectomized rats
Abstract
Introduction: The direct effect of follicle-stimulating hormone (FSH) on bone resorption has been demonstrated recently. The aim of this study was to evaluate the effect of FSH inhibitor leuprorelin (LE) on alveolar bone loss resulting from experimental periapical lesions in ovariectomized (OVX) rats.
Methods: Twenty-seven female rats were randomly assigned into 4 groups and subjected to ovariectomy or sham surgery (1.6 mg/kg body weight LE or vehicle was injected immediately). One week after surgery, the pulp of each rat's bilateral lower first molars was exposed to the oral environment. Three weeks after pulpal exposure, all the animals were killed, and bilateral mandibles were extracted for histologic processing. Radiographic and histologic examination for periapical bone loss area, enzyme histochemical examination for tartrate-resistant acid phosphatase (TRAP), and immunohistochemical examination for FSH receptor (FSHR) were performed.
Results: LE significantly decreased the alveolar bone loss area and osteoclast occurrence compared with non-LE treatment ovariectomized rats (P < .05), and the number of FSHR-positive cells was significantly correlated with alveolar bone loss area (r = 0.796, P < .01).
Conclusions: LE has protective effects on alveolar bone loss resulting from experimental periapical lesions in OVX rats.
Copyright (c) 2010. Published by Elsevier Inc.
Similar articles
-
FSH aggravates periodontitis-related bone loss in ovariectomized rats.J Dent Res. 2010 Apr;89(4):366-71. doi: 10.1177/0022034509358822. Epub 2010 Feb 5. J Dent Res. 2010. PMID: 20139335
-
Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats.J Endod. 2007 Nov;33(11):1304-8. doi: 10.1016/j.joen.2007.07.011. Epub 2007 Aug 23. J Endod. 2007. PMID: 17963952
-
Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin.J Endod. 2012 Jul;38(7):943-7. doi: 10.1016/j.joen.2012.03.010. Epub 2012 Apr 21. J Endod. 2012. PMID: 22703658
-
Pathogenesis of induced rat periapical lesions.Oral Surg Oral Med Oral Pathol. 1994 Oct;78(4):494-502. doi: 10.1016/0030-4220(94)90044-2. Oral Surg Oral Med Oral Pathol. 1994. PMID: 7800381 Review.
-
The Relationship between Follicle-stimulating Hormone and Bone Health: Alternative Explanation for Bone Loss beyond Oestrogen?Int J Med Sci. 2018 Sep 7;15(12):1373-1383. doi: 10.7150/ijms.26571. eCollection 2018. Int J Med Sci. 2018. PMID: 30275766 Free PMC article. Review.
Cited by
-
Neuroendocrinology of bone.Pituitary. 2024 Dec;27(6):761-777. doi: 10.1007/s11102-024-01437-5. Epub 2024 Aug 3. Pituitary. 2024. PMID: 39096452 Review.
-
Independent Skeletal Actions of Pituitary Hormones.Endocrinol Metab (Seoul). 2022 Oct;37(5):719-731. doi: 10.3803/EnM.2022.1573. Epub 2022 Sep 28. Endocrinol Metab (Seoul). 2022. PMID: 36168775 Free PMC article.
-
FSH Beyond Fertility.Front Endocrinol (Lausanne). 2019 Mar 19;10:136. doi: 10.3389/fendo.2019.00136. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30941099 Free PMC article. Review.
-
FSH Level and Changes in Bone Mass and Body Composition in Older Women and Men.J Clin Endocrinol Metab. 2021 Sep 27;106(10):2876-2889. doi: 10.1210/clinem/dgab481. J Clin Endocrinol Metab. 2021. PMID: 34212197 Free PMC article.
-
Bone circuitry and interorgan skeletal crosstalk.Elife. 2023 Jan 19;12:e83142. doi: 10.7554/eLife.83142. Elife. 2023. PMID: 36656634 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
